Octreotide for injection

What is Octreotide for Injection?
Octreotide for Injection is a synthetic protein that mimics the natural hormone somatostatin. It is a potent somatostatin analogue that inhibits the release of several hormones and secretory proteins, including growth hormone, insulin, and glucagon. It is vital in managing rare endocrine tumors and specialized gastrointestinal conditions where hormonal overproduction causes debilitating symptoms.
Uses of Octreotide for Injection
Acromegaly: To reduce blood levels of growth hormone and IGF-I in patients who do not respond to surgery or radiation.
Carcinoid Tumors: To manage severe diarrhea and sudden reddening of the face/neck (flushing) caused by metastatic carcinoid tumors.
Vasoactive Intestinal Peptide Tumors (VIPomas): Treatment of profuse, watery diarrhea associated with these tumors.
Esophageal Varices: Used off-label in acute settings to control bleeding by reducing portal venous pressure.
Dumping Syndrome: Management of severe post-surgical gastrointestinal symptoms in patients unresponsive to dietary changes.
How Does Octreotide for Injection Work?
Octreotide works by binding to somatostatin receptors throughout the body. Its primary action is to inhibit the secretion of various hormones (such as Growth Hormone) and gastrointestinal peptides (such as Serotonin and Gastrin). This reduces intestinal fluid secretion and slows down gastrointestinal motility, providing rapid relief from hormonal and secretory imbalances.
FAQs on Octreotide for Injection
1. What is the difference between Octreotide IR and Octreotide LAR? Octreotide IR (Immediate Release) is typically injected subcutaneously or intravenously multiple times a day for acute symptom control. Octreotide LAR (Long-Acting Release) is a "Depot" formulation injected intramuscularly once every four weeks for long-term maintenance.
2. Can Octreotide be used for acute gastrointestinal bleeding? Yes, in clinical settings, Octreotide is often used as an adjunct therapy for acute bleeding of esophageal varices in patients with liver cirrhosis, as it helps constrict the blood vessels in the gut.
3. Does Octreotide affect blood sugar levels? Because Octreotide inhibits the release of both insulin and glucagon, it can cause fluctuations in blood glucose levels (both hyperglycemia and hypoglycemia). Patients, especially those with diabetes, should monitor their blood sugar closely during treatment.
Therapeutic Category
Others (Hormones / Antineoplastic Adjunct)
Looking for a reliable Octreotide for Injection manufacturer? Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and export supplies. We specialize in high-quality hormonal injectables and complex formulations for global markets.